Latest Topics
| Member Statement
May 1, 2009
Statement Regarding Ministry of Health & Long-Term Care Release of April 27, 2009 :
Please read
| HNS Agreement Update
January 10, 2009
Important notice about the HNS Agreement: Please read |
Important Downloads:
|
Dispensing Fee Change for Blister pack The IPO has drafted a template letter that can be sent to MPPs in Ontario expressing concern about the new regulatory changes to the dispensing of pill packs. Members can print off this letter and provide it to their patients to send to their local MPP.
|
Submission to OPDP on the ProposedFramework for Competitive Agreements
“The regulations associated with Bill 102 are unprecedented
in the industry. The new law has presented some real
challenges for Independent Pharmacists.” | Ben Shenouda
IPO President |
In 2006, the Government of Ontario passed into legislation the Transparent Drug System for Patients Act (TDSPA), which brought about major changes to the province’s prescription drug system. Changes include onerous new reporting, service and inventory requirements, stipulating how pharmacists can spend their professional allowances, and the reduction of rebates which pharmacies use to cover operating and service delivery costs, to name just a few.
While these sweeping changes have affected the bottom-line of pharmacy operators across Ontario, they have hit independent pharmacists particularly hard, with many having difficulty simply making ends meet. | THE IMPACT | Learn more about the real impact of the TDSPA/Bill 102
| | OUR ACTION | Learn more about what the IPO is doing to counter the effects of the TDSPA (Bill 102) on its members,
|
| LINKS |  |
|
